Previous animal investigations demonstrating that intrathecal opiates will produce a long lasting and profound analgesia, have resulted in the use of spinal morphine as a mode of therapy in the clinical control of acute and chronic pain. The present proposal represents an expansion of our original work. (1) Pharmacology of the spinal opiate receptor systems in the primate related to analgesia: Intrathecal dose response curves will be obtained for opiate agonists reported to have selective affinity for subpopulations of opiate receptors (morphine, morphicetin, Mu; d-ala2-d-leu5-enkephalin, Delta; bremazocine, U50488, Kappa; nalbuphine, partial agonist). Quantitative antagonism of these antinociceptive effects with systemic naloxone and the rate of intrathecal tolerance development will be examined. Following development of tolerance, we will determine if cross tolerance exists between these intrathecal agonists. This will assess the independence of the spinal receptor populations acted upon by these several agents. (2) Pharmacology of spinal adrenergic receptor systems: Our previous work has demonstrated the significant analgesic effect resulting from intrathecal Alpha2-agonists (e.g. ST-91, a clonidine analogue). Sensitivity to antagonism by yohimbine and the time course of tolerance development will be examined. (3) Interactions of intrathecally administered morphine with Alpha2-agonists, local anesthetics and non-Mu opiate agonists: Previous studies have indicated that there is a potentiative interaction between Alpha2-agonists and opiates. The present studies will systematically examine and quantify the nature of the interaction in terms of their effect on pain, motor and autonomic function. (4) Effect of spinal administration in primate of morphine, ST-91, and morphine + ST-91 on behavior and long term changes in the pain threshold. (5) The effects of intrathecal opiates and St-91 on spinal cord blood flow during hypo and hypercarbia. (6) Distribution and kinetics of intrathecally and epidurally administered opiates. These studies will assess the movement of opiates having different lipid partition coefficients from the epidural and intrathecal space into: cisternal CSF, peripheral venous system, the peridural plexus (Batson's plexus), and the great cerebral veins. These experiments will provide insight into the underlying mechanisms of delayed respiratory depression.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA002110-06
Application #
3207120
Study Section
Pharmacology I Research Subcommittee (DABR)
Project Start
1983-07-01
Project End
1986-06-30
Budget Start
1985-07-01
Budget End
1986-06-30
Support Year
6
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Gregus, Ann M; Buczynski, Matthew W; Dumlao, Darren S et al. (2018) Inhibition of spinal 15-LOX-1 attenuates TLR4-dependent, nonsteroidal anti-inflammatory drug-unresponsive hyperalgesia in male rats. Pain 159:2620-2629
Podvin, Sonia; Yaksh, Tony; Hook, Vivian (2016) The Emerging Role of Spinal Dynorphin in Chronic Pain: A Therapeutic Perspective. Annu Rev Pharmacol Toxicol 56:511-33
Park, H J; Sandor, K; McQueen, J et al. (2016) The effect of gabapentin and ketorolac on allodynia and conditioned place preference in antibody-induced inflammation. Eur J Pain 20:917-25
Woller, Sarah A; Ravula, Satheesh B; Tucci, Fabio C et al. (2016) Systemic TAK-242 prevents intrathecal LPS evoked hyperalgesia in male, but not female mice and prevents delayed allodynia following intraplantar formalin in both male and female mice: The role of TLR4 in the evolution of a persistent pain state. Brain Behav Immun 56:271-80
Sikandar, Shafaq; Gustavsson, Ynette; Marino, Marc J et al. (2016) Effects of intraplantar botulinum toxin-B on carrageenan-induced changes in nociception and spinal phosphorylation of GluA1 and Akt. Eur J Neurosci 44:1714-22
Pellett, Sabine; Yaksh, Tony L; Ramachandran, Roshni (2015) Current status and future directions of botulinum neurotoxins for targeting pain processing. Toxins (Basel) 7:4519-63
Woller, S A; Corr, M; Yaksh, T L (2015) Differences in cisplatin-induced mechanical allodynia in male and female mice. Eur J Pain 19:1476-85
Ramachandran, Roshni; Lam, Carmen; Yaksh, Tony L (2015) Botulinum toxin in migraine: Role of transport in trigemino-somatic and trigemino-vascular afferents. Neurobiol Dis 79:111-22
Ramachandran, Roshni; Yaksh, Tony L (2014) Therapeutic use of botulinum toxin in migraine: mechanisms of action. Br J Pharmacol 171:4177-92
Park, Hue Jung; Stokes, Jennifer A; Corr, Maripat et al. (2014) Toll-like receptor signaling regulates cisplatin-induced mechanical allodynia in mice. Cancer Chemother Pharmacol 73:25-34

Showing the most recent 10 out of 102 publications